Brief: Cytodyn Receives First Purchase Order From Chiral Pharma Corporation For Use Of Leronlimab Under CSP For Covid-19 Patients In The Philippines
01/06/2021 14:16
June 1 (Reuters) - Cytodyn Inc CYDY.PK :
* CYTODYN RECEIVES FIRST PURCHASE ORDER FROM CHIRAL PHARMA
CORPORATION FOR USE OF LERONLIMAB UNDER CSP FOR COVID-19
PATIENTS IN THE PHILIPPINES
Source text for Eikon: ID:nGNX94FpPC
Further company coverage: CYDY.PK
((reuters.briefs@thomsonreuters.com;))
Recent news on Cytodyn
See all newsBrief: Cytodyn Appoints Robert E. Hoffman As Chief Executive Officer
Brief: Cytodyn Closes $17.5 Million Financing To Fund Continued Development Of Leronlimab
Brief: CytoDyn Inc Files For Offering Of Up To 120 Million Shares Of Common Stock By Selling Stockholder - SEC Filing
Brief: Cytodyn Files For Mixed Shelf Of Up To $100 Million - SEC Filing
Brief: CytoDyn Announces First Patient Dosed in Phase II Oncology Trial in Colorectal Cancer